Viva Vision Biotech's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·The complete investor list: 26 names
- ·Watch Viva Vision Biotech: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Viva Vision Biotech funding history
No funding rounds for Viva Vision Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Viva Vision Biotech valuation
Viva Vision Biotech's last reported valuation was $257 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
How Viva Vision Biotech's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Viva Vision Biotech, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Viva Vision Biotech
- What is Viva Vision Biotech worth?
- Viva Vision Biotech is valued at $256.6M as of Oct 2026. Viva Vision Biotech's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- How much has Viva Vision Biotech raised?
- Viva Vision Biotech has raised $107.4M in total funding across its recorded rounds.